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143 Does increased frequency of sputum sampling alter antibiotic
choice during exacerbations?
L.R. Boyle1, D.E. Stronge1, J.M. Bradley1,2, J.S. Elborn1. 1Adult CF Unit, Belfast
City Hospital, Belfast, United Kingdom; 2School of Health Sciences, University of
Ulster, Belfast, United Kingdom
Background: UK CF Trust clinical guidelines recommend that sputum samples
are obtained at the onset of a respiratory exacerbation and that antibiotic choice
is based on resistance patterns of recent sputum cultures. An audit was performed
within our adult CF unit to determine how often sputum samples are collected
during an inpatient admission for IVs and whether admission sputum samples are
used to make decisions regarding changes in antibiotic treatment.
Methods: A retrospective study of all inpatient record forms in a 6 month period.
Information on frequency of sampling and antibiotic treatment was collected
from all CF inpatients with chronic Pseudomonas aeruginosa (n = 21). Data was
categorised into time periods and summarised using descriptive statistics.
Results: 69 sputum samples were collected during 31 admissions (median, 3; range,
2−6 samples per admission). 12 repeat samples were obtained within 3 days of
admission. The most common length of time for retest was 4−7 days. Common
reasons for repeat sputum samples included local policy, detection of atypical
organisms, deterioration in spirometry and appearance of sputum. Antibiotics were
changed on only two occasions, however this was due to slow improvement and
suspected portacath infection rather than change in sputum resistance pattern.
Conclusion: In our CF centre antibiotic treatment is seldom changed on the basis
of admission sputum culture results. Although an admission sputum sample may be
important repeated sampling may be unnecessary. Collaboration with bacteriology
laboratories is essential to develop and implement local guidelines in order to
improve the efﬁciency of this service.
144 The signiﬁcance of complete pulmonary function test data in the
respiratory exacerbation of cystic ﬁbrosis
D. Shoseyov, R. Hammami, E. Kerem. Cystic Fibrosis Center, Hadassah Medical
Center, Jerusalem, Israel
Respiratory exacerbation in cystic ﬁbrosis patients is characterized by increased
sputum that may become more purulent. The detection of the exacerbation is based
mainly on clinical subjective parameters. FEV1 measurements are accepted as gold
standard to be used for the life-time of the patient but do not adapt fast enough
after resolution of an exacerbation. We compared parameters that are affected by
the uneven distribution of ventilation in the lung due to increase sputum.
Methods: A Zen body plethysmograph was used to measure TLC, FEV1 and DLCO
(CO/CH3 mixture). TLC was also calculated by the volume of CH3, the angle of the
slope of phase III was calculated in 7 CF patients at the beginning of the respiratory
exacerbation and after 2 weeks of antibiotic treatment. Patients were 19−26 years
old (4M/3F).
Results: FEV1 changed by 9.8+7.41%, TLC(pleth) was stable 0.9+8.7%, RV/TLC
decreased by 23.8+ 23.4% and TLC(gas) increased by 5+36.6%. The difference
between TLC(pleth) and TLC(gas) decrease was-24+26.4%.
Conclusion: Despite the small number of patients in the study we show that the
changes in the parameters affected by the unevenness of distribution of ventilation
(m/p reﬂecting the increased sputum in the airway) are more pronounced than
FEV1.
145 Clinical correlates of hypermutator P. aeruginosa in CF
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Introduction: Hypermutator P. aeruginosa constitutes an important part of the
microbiology of the CF lung, but the clinical correlates of their presence have not
been reported in the literature.
Methods: 161 consecutive P. aeruginosa isolates from 40 patients with CF were
collected over a period of 6 months. Each was processed, in triplicate, as follows: a
single colony was cultured overnight in 20ml of Mueller-Hinton broth, centrifuged
then resuspended in 1ml phosphate-buffered saline and serially diluted. 10 ml of
each dilution was spotted onto plain MH agar and MH agar containing 300mg/ml
rifampicin then incubated at 37ºC. Mutant frequencies were determined by com-
paring colony counts on the two agar plates, and isolates with a result greater than
20 times that of strain PAO1 were considered hypermutators.
Results: 47 (29.2%) isolates were hypermutators, and these were isolated from
16 (40.0%) patients. Mean FEV1 was lower in patients with hypermutators (40.2%
predicted vs 58.6%, p = 0.008, Mann-Whitney), and so was mean FEV1/FVC
(53.3% vs 64.2%, p = 0.028, Mann-Whitney). There was a trend towards associ-
ation with lower BMI (mean 20.6 vs 22.5, p = 0.058, Mann-Whitney) and higher
azithromycin use (64.3% of patients vs 29.2%, p = 0.087, Chi2). No association was
found with age, sex, number of courses of intravenous antibiotics in the preceding
year, presence of liver disease, presence of diabetes, use of nebulized tobramycin,
or use of nebulized colistin.
Conclusions: The presence of hypermutator strains of P. aeruginosa in adults
patients with CF was associated with poorer lung function. There was a trend
towards an association with lower BMI and with azithromycin use.
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Lung transplant (LT) patients are a special risk group of infection, particularly those
with cystic ﬁbrosis (CF).
Objective: To analyze Mycobacterium abscessus infection in our LT series.
Material and Methods: Global number of patients 317 (65 with CF). Study period:
February 1990-December 2006. Isolation of the microorganism from different
biological samples.
Results: M. abscessus was isolated in 3 patients (all CF): 1 in Knee; 1 in
bronchoalveolar lavage (BAL) and in only 1 patient was a disseminated infection
established. One year after LT, a small subcutaneous nodule was casually detected
beneath the thoracotomy incision, with no other ﬁndings. M. abscessus was isolated
from the aspirated material, and posteriorly from bone marrow, blood culture, BAL
and bronchial biopsy. Antecedents prior to LT: S. aureus colonization and sputum
positivity for Aspergillus fumigatus and Scedosporium apioespermum. Tuberculin
testing and repeated sputum cultures in Lo¨wenstein medium proved negative for
tuberculosis. Treatment was started on the basis of the antibiogram ﬁndings with
ciproﬂoxacin and linezolid. The latter was suspended after one month due to
bicytopenia, with replacement by clarithromycin for 3 months. Eighteen months
later the patient remains asymptomatic.
Conclusions: (1) The incidence of M. abscessus infection in our series is very low
and corresponding to CF patients. (2) The infected patient described is the only
case with sepsis and multisystem spread reported. (3) The important mortality of
such cases reported in the literature makes early diagnosis and treatment essential.
